Revisiting STAT3 signalling in cancer: new and unexpected biological functions
暂无分享,去创建一个
Hua Yu | Andreas Herrmann | Hua Yu | R. Jove | A. Herrmann | Heehyoung Lee | R. Buettner | Richard Jove | Ralf Buettner | Heehyoung Lee
[1] E. Elinav,et al. Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer , 2013, Proceedings of the National Academy of Sciences.
[2] J. Darnell,et al. The role of STATs in transcriptional control and their impact on cellular function , 2000, Oncogene.
[3] T. Kilpatrick,et al. LIF receptor signaling modulates neural stem cell renewal , 2004, Molecular and Cellular Neuroscience.
[4] J. Brugge,et al. IL-6 involvement in epithelial cancers. , 2007, The Journal of clinical investigation.
[5] Ke Huang,et al. STAT3 acetylation-induced promoter methylation is associated with downregulation of the ARHI tumor-suppressor gene in ovarian cancer. , 2013, Oncology reports.
[6] S. Spiegel,et al. Sphingosine Kinases and Sphingosine-1-Phosphate Are Critical for Transforming Growth Factor β-Induced Extracellular Signal-Regulated Kinase 1 and 2 Activation and Promotion of Migration and Invasion of Esophageal Cancer Cells , 2008, Molecular and Cellular Biology.
[7] Hua Yu,et al. Toll-like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist-based immunotherapy. , 2009, Cancer research.
[8] Hua Yu,et al. Tumour immunology: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment , 2007, Nature Reviews Immunology.
[9] Jun Hee Lee,et al. Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression , 2010, Cell.
[10] Y. Horiguchi,et al. Serum interleukin 6 as a prognostic factor in patients with prostate cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[11] F. Vesuna,et al. Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells , 2009, Oncogene.
[12] S. Ponnusamy,et al. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. , 2010, Future oncology.
[13] Ozge Canli,et al. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. , 2009, Cancer cell.
[14] Ying Liang,et al. Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance. , 2013, The Journal of clinical investigation.
[15] S. Grivennikov. IL-11: a prominent pro-tumorigenic member of the IL-6 family. , 2013, Cancer cell.
[16] 杉村 啓二郎. Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma , 2013 .
[17] Hua Yu,et al. The STATs of cancer — new molecular targets come of age , 2004, Nature Reviews Cancer.
[18] J. Tobias,et al. Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cells. , 2008, Cancer research.
[19] David García-Dorado,et al. TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. , 2009, Cancer cell.
[20] J. Lin,et al. TLR4 knockout protects mice from radiation-induced thymic lymphoma by downregulation of IL6 and miR-21 , 2011, Leukemia.
[21] J. Radich,et al. IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development. , 2011, Cancer cell.
[22] Y. Hannun,et al. Role for sphingosine kinase 1 in colon carcinogenesis , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] R. Proia,et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 , 2004, Nature.
[24] M. Golzio,et al. Sphingosine Kinase-1 Is Central to Androgen-Regulated Prostate Cancer Growth and Survival , 2009, PloS one.
[25] R. A. Hall,et al. Fine-tuning of GPCR activity by receptor-interacting proteins , 2009, Nature Reviews Molecular Cell Biology.
[26] T. Witzig,et al. Elevated serum IL-10 levels in diffuse large B-cell lymphoma: a mechanism of aberrant JAK2 activation. , 2012, Blood.
[27] Yi-Wen Chang,et al. Direct reprogramming of stem cell properties in colon cancer cells by CD44 , 2011, The EMBO journal.
[28] John D. Minna,et al. miR-337-3p and Its Targets STAT3 and RAP1A Modulate Taxane Sensitivity in Non-Small Cell Lung Cancers , 2012, PloS one.
[29] Valeriy R. Korostyshevskiy,et al. Mechanisms of Unphosphorylated STAT3 Transcription Factor Binding to DNA* , 2012, The Journal of Biological Chemistry.
[30] Andrew J. Bannister,et al. LIF independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell disease , 2010, Nature Cell Biology.
[31] M. Neurath,et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo , 2000, Nature Medicine.
[32] R. Figlin,et al. Microenvironment and Immunology Targeting Stat3 in the Myeloid Compartment Drastically Improves the in Vivo Antitumor Functions of Adoptively Transferred T Cells , 2022 .
[33] C. Hunter,et al. gp130 at the nexus of inflammation, autoimmunity, and cancer , 2010, Journal of leukocyte biology.
[34] M. Clarke,et al. Stem Cells and Cancer: Two Faces of Eve , 2006, Cell.
[35] Michael L. Wang,et al. Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells. , 2010, Blood.
[36] D. Scadden,et al. Differential regulation of myeloid leukemias by the bone marrow microenvironment , 2012, Nature Medicine.
[37] J. Karras,et al. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. , 2008, Journal of Clinical Investigation.
[38] J. P. Hobson,et al. Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells. , 2002, Experimental cell research.
[39] J. Darnell,et al. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. , 1994, Science.
[40] M. Kortylewski,et al. Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity. , 2014, Blood.
[41] T. Hirano,et al. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130 , 1989, Cell.
[42] Hsiu‐Po Wang,et al. Sphingosine kinase-1 mediates BCR/ABL-induced upregulation of Mcl-1 in chronic myeloid leukemia cells , 2007, Oncogene.
[43] Roberta Galli,et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response , 2012, Proceedings of the National Academy of Sciences.
[44] X. Chen,et al. Stat3-coordinated Lin-28–let-7–HMGA2 and miR-200–ZEB1 circuits initiate and maintain oncostatin M-driven epithelial–mesenchymal transition , 2013, Oncogene.
[45] D. Nam,et al. Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. , 2013, Cancer cell.
[46] Ursula A White,et al. The gp130 receptor cytokine family: regulators of adipocyte development and function. , 2011, Current pharmaceutical design.
[47] Hua Yu,et al. TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo. , 2013, Blood.
[48] S. Milstien,et al. The outs and the ins of sphingosine-1-phosphate in immunity , 2011, Nature Reviews Immunology.
[49] D. Levy,et al. STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis. , 2011, Cancer research.
[50] Kevin Struhl,et al. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. , 2009, Cancer research.
[51] T. Putoczki,et al. More than a sidekick: the IL‐6 family cytokine IL‐11 links inflammation to cancer , 2010, Journal of leukocyte biology.
[52] Hua Yu,et al. Role of Stat3 in suppressing anti-tumor immunity. , 2008, Current opinion in immunology.
[53] Ming Li,et al. The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis. , 2013, Neoplasia.
[54] Sean J Morrison,et al. Cancer stem cells: impact, heterogeneity, and uncertainty. , 2012, Cancer cell.
[55] A. Thor,et al. Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers , 2012, Cell cycle.
[56] Hideaki Tahara,et al. Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells , 2011, Proceedings of the National Academy of Sciences.
[57] Hua Yu,et al. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity , 2005, Nature Medicine.
[58] R. Jove,et al. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[59] Tongshan Wang,et al. MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation , 2012, Cancer biology & therapy.
[60] S. Chiou,et al. Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway. , 2012, Lung cancer.
[61] Hua Yu,et al. G-protein-coupled Receptor Agonist BV8/Prokineticin-2 and STAT3 Protein Form a Feed-forward Loop in Both Normal and Malignant Myeloid Cells* , 2013, The Journal of Biological Chemistry.
[62] M. Sata,et al. Essential Roles of IL-6 Trans-Signaling in Colonic Epithelial Cells, Induced by the IL-6/Soluble–IL-6 Receptor Derived from Lamina Propria Macrophages, on the Development of Colitis-Associated Premalignant Cancer in a Murine Model , 2009, The Journal of Immunology.
[63] J. Darnell. Transcription factors as targets for cancer therapy , 2002, Nature Reviews Cancer.
[64] Atsuo Ochi,et al. Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans. , 2012, The Journal of clinical investigation.
[65] R. Proia,et al. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone , 2004, Nature Immunology.
[66] R. Figlin,et al. S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. , 2012, Cancer cell.
[67] John K. Heath,et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides , 1988, Nature.
[68] J. Darnell,et al. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.
[69] Sarah Spiegel,et al. Interleukin-1 Regulates the Expression of Sphingosine Kinase 1 in Glioblastoma Cells* , 2009, Journal of Biological Chemistry.
[70] Libing Song,et al. Acylglycerol kinase augments JAK2/STAT3 signaling in esophageal squamous cells. , 2013, The Journal of clinical investigation.
[71] Yiling Lu,et al. Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. , 2006, Cancer cell.
[72] Hua Yu,et al. S1PR1 is an effective target to block STAT3 signaling in activated B cell-like diffuse large B-cell lymphoma. , 2012, Blood.
[73] Kevin Struhl,et al. An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation , 2009, Cell.
[74] Andrew J. Bannister,et al. JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin , 2009, Nature.
[75] Hua Yu,et al. STATs in cancer inflammation and immunity: a leading role for STAT3 , 2009, Nature Reviews Cancer.
[76] O. Sieber,et al. Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically. , 2013, Cancer cell.
[77] P. Fawcett,et al. Function of Mitochondrial Stat3 in Cellular Respiration , 2009, Science.
[78] S. Milstien,et al. Sphingosine kinase 1 is required for migration, proliferation and survival of MCF‐7 human breast cancer cells , 2005, FEBS letters.
[79] S. Lang,et al. Toll-like Receptors in Regulatory T Cells of Patients With Head and Neck Cancer. , 2010, Archives of otolaryngology--head & neck surgery.
[80] Shuang Chen,et al. Toll-Like Receptor 2 Signaling Protects Mice from Tumor Development in a Mouse Model of Colitis-Induced Cancer , 2010, PloS one.
[81] R. Fischmeister,et al. A new regulation of IL-6 production in adult cardiomyocytes by beta-adrenergic and IL-1 beta receptors and induction of cellular hypertrophy by IL-6 trans-signalling. , 2010, Cellular signalling.
[82] Yunlong Liu,et al. Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistance , 2009, Bioinform..
[83] R. McLendon,et al. Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival and Tumor Growth , 2009, Stem cells.
[84] E. Goetzl,et al. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network , 2005, Nature Reviews Immunology.
[85] Fabio Pellegrini,et al. Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review , 2013, PloS one.
[86] D. Banerjee,et al. Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu. , 2010, Experimental cell research.
[87] Q. Ye,et al. MicroRNA‐26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin‐6‐Stat3 pathway , 2013, Hepatology.
[88] Jing-Yuan Fang,et al. Inhibition of JAK2/STAT3 signalling induces colorectal cancer cell apoptosis via mitochondrial pathway , 2012, Journal of cellular and molecular medicine.
[89] P. Heinrich,et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. , 2003, The Biochemical journal.
[90] S. Pan,et al. Kaposi's Sarcoma-Associated Herpesvirus (KSHV) vIL-6 Promotes Cell Proliferation and Migration by Upregulating DNMT1 via STAT3 Activation , 2014, PloS one.
[91] P. Jung,et al. Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. , 2012, Cancer cell.
[92] Y. E. Chin,et al. Stat3 Dimerization Regulated by Reversible Acetylation of a Single Lysine Residue , 2005, Science.
[93] L. Eckmann,et al. STAT3 and its activators in intestinal defense and mucosal homeostasis , 2010, Current opinion in gastroenterology.
[94] A. Larner,et al. Toward a new STATe: the role of STATs in mitochondrial function. , 2014, Seminars in immunology.
[95] B. Viollet,et al. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. , 2007, Cancer research.
[96] A. Kowalski-Chauvel,et al. A Novel Mechanism for JAK2 Activation by a G Protein-coupled Receptor, the CCK2R , 2005, Journal of Biological Chemistry.
[97] Mithat Gönen,et al. The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors. , 2011, The Journal of clinical investigation.
[98] A. Riggs,et al. Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation , 2012, Proceedings of the National Academy of Sciences.
[99] F. Peale,et al. Bv8 regulates myeloid-cell-dependent tumour angiogenesis , 2007, Nature.
[100] Y. Saeki,et al. A Point Mutation of Tyr-759 in Interleukin 6 Family Cytokine Receptor Subunit gp130 Causes Autoimmune Arthritis , 2002, The Journal of experimental medicine.
[101] Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. , 2012, Cancer research.
[102] Hua Yu,et al. Stat3-induced S1PR1 expression is critical for persistent Stat3 activation in tumors , 2010, Nature Medicine.
[103] J. Turkson,et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. , 1999, Immunity.
[104] A. Parker,et al. STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation. , 2012, Cancer cell.
[105] Mallika Singh,et al. Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression , 2008, Proceedings of the National Academy of Sciences.
[106] S. Haggarty,et al. Histone deacetylase 3 as a novel therapeutic target in multiple myeloma , 2014, Leukemia.
[107] T. Jiang,et al. TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients , 2010, BMC Cancer.
[108] David Artis,et al. Intestinal epithelial cells: regulators of barrier function and immune homeostasis , 2014, Nature Reviews Immunology.
[109] M. Caligiuri,et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.
[110] Hua Yu,et al. In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses , 2009, Nature Biotechnology.
[111] Eric B Haura,et al. Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer , 2005, Nature Clinical Practice Oncology.
[112] A. Riggs,et al. Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance , 2013, Proceedings of the National Academy of Sciences.
[113] Eugene Y. Kim,et al. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. , 2013, Cancer cell.
[114] Stem cells: Bad seeds , 2013, Nature.
[115] R. Figlin,et al. Myeloid Clusters Are Associated with a Pro-Metastatic Environment and Poor Prognosis in Smoking-Related Early Stage Non-Small Cell Lung Cancer , 2013, PloS one.
[116] D. Santini,et al. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. , 2007, The Journal of clinical investigation.
[117] J. Dick,et al. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.
[118] R. Proia,et al. The alliance of sphingosine-1-phosphate and its receptors in immunity , 2008, Nature Reviews Immunology.
[119] Sarah Spiegel,et al. Sphingosine-1-phosphate signaling and its role in disease. , 2012, Trends in cell biology.
[120] Timothy C Wang,et al. Inflammation and cancer: IL-6 and STAT3 complete the link. , 2009, Cancer cell.
[121] Tetsuro Tsujimoto,et al. Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis , 2012, PloS one.
[122] Joel Greshock,et al. MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. , 2008, Cancer research.
[123] Hua Yu,et al. Loss of androgen receptor expression promotes a stem-like cell phenotype in prostate cancer through STAT3 signaling. , 2014, Cancer research.
[124] Hua Yu,et al. Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice , 2009, Glia.
[125] E. Montserrat,et al. Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma. , 2009, Blood.
[126] M. Karin,et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. , 2009, Cancer cell.
[127] Jeffrey S. Damrauer,et al. Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal. , 2014, The Journal of clinical investigation.
[128] Yuan Zhang,et al. Both miR-17-5p and miR-20a Alleviate Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating STAT3 Expression , 2011, The Journal of Immunology.
[129] K. Lim,et al. Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. , 2007, Genes & development.
[130] J. Fenton,et al. Adipokine regulation of colon cancer: Adiponectin attenuates interleukin‐6‐induced colon carcinoma cell proliferation via STAT‐3 , 2010, Molecular carcinogenesis.
[131] G. Inghirami,et al. NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells. , 2009, Cancer research.
[132] G. Gallia,et al. TLR9 is critical for glioma stem cell maintenance and targeting. , 2014, Cancer research.
[133] K. Struhl,et al. Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth , 2012, Proceedings of the National Academy of Sciences.
[134] J. Uhm,et al. The transcriptional network for mesenchymal transformation of brain tumours , 2010 .
[135] Guido Gerken,et al. Toll-like receptor 4 variant D299G induces features of neoplastic progression in Caco-2 intestinal cells and is associated with advanced human colon cancer. , 2011, Gastroenterology.
[136] Hua Yu,et al. Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice. , 2008, The Journal of clinical investigation.
[137] P. Dent,et al. Mitochondrial Localized Stat3 Promotes Breast Cancer Growth via Phosphorylation of Serine 727* , 2013, The Journal of Biological Chemistry.
[138] Leah E. Mechanic,et al. Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer. , 2011, Journal of the National Cancer Institute.
[139] G. Stark,et al. How cells respond to interferons. , 1998, Annual review of biochemistry.
[140] T. Kwok,et al. Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3 , 2008, Apoptosis.
[141] Hong-Ying Zhou,et al. Systematic analysis of microRNA involved in resistance of the MCF-7 human breast cancer cell to doxorubicin , 2010, Medical oncology.
[142] Zhaoshi Jiang,et al. Tumour‐secreted miR‐9 promotes endothelial cell migration and angiogenesis by activating the JAK‐STAT pathway , 2012, The EMBO journal.
[143] J. Visvader,et al. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.
[144] Hua Yu,et al. IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway , 2009, The Journal of experimental medicine.
[145] R. Medzhitov,et al. Toll-like receptors and cancer , 2009, Nature Reviews Cancer.
[146] B. Cochran,et al. STAT3 Is Required for Proliferation and Maintenance of Multipotency in Glioblastoma Stem Cells , 2009, Stem cells.
[147] M. Neurath,et al. Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11b(high)Gr1(low) macrophages. , 2011, The Journal of clinical investigation.
[148] N. Maitland,et al. JAK-STAT blockade inhibits tumor initiation and clonogenic recovery of prostate cancer stem-like cells. , 2013, Cancer research.
[149] F. Lee,et al. The genes for leukemia inhibitory factor and interleukin-6 are expressed in mouse blastocysts prior to the onset of hemopoiesis , 1990, Molecular and cellular biology.
[150] Hua Yu,et al. S1PR1 is crucial for accumulation of regulatory T cells in tumors via STAT3. , 2014, Cell reports.
[151] D. Levy,et al. Mitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation , 2009, Science.
[152] R. McLendon,et al. Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3. , 2011, Cancer cell.
[153] J. Scheller,et al. Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. , 2011, The Journal of clinical investigation.
[154] Xin-Yuan Fu,et al. Mouse hematopoietic cell-targeted STAT3 deletion: stem/progenitor cell defects, mitochondrial dysfunction, ROS overproduction, and a rapid aging-like phenotype. , 2012, Blood.